23.12.2021 11:00:00
|
Philips and IJsselland Hospital sign long-term technology partnership
December 23, 2021
- 12-year agreement focuses on innovation, digitalization and optimization across patient monitoring and radiology solutions
- Philips will facilitate remote care and telehealth programs
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has signed a 12-year strategic partnership with IJsselland Hospital (Capelle aan den Ijssel, The Netherlands). As the hospital’s strategic technology partner, Philips will target improved care for patients and care providers at IJsselland Hospital and in the surrounding region. The collaboration will focus on innovation, digitalization and optimization, and includes the purchase of patient monitoring and radiology solutions including CT and MRI systems.
Home monitoring collaboration expanded
In addition to the new strategic partnership, Philips and IJsselland Hospital plan to expand their existing home monitoring partnership for patients with heart failure and COPD. Philips will provide clinical and patient decision support software which enables implementation of remote health and care programs and facilitates collaboration between different healthcare providers.
"Technological developments in healthcare are currently moving very fast,” said Albert van Wijk, Chairman of IJsselland Hospital’s Board of Directors. "As a regional hospital, we want to keep up with these developments to provide the best care for our patients. We have chosen Philips as a technology partner to jointly develop the hospital of the future. This will be good for our patients and our healthcare professionals. Moreover, Philips’ vision fits well with our strategy.”
"Over the past year, we have worked with IJsselland Hospital to convert their strategy and challenges into a partnership,” said Léon Kempeneers, Health Systems, Philips Benelux. "I am very proud of this partnership, in which we don’t focus solely on technology but look more broadly at the challenges the hospital faces. A great deal of attention is paid to innovation, which is why we are starting a joint fund for innovation and optimization. We also want to work explicitly on optimizing care processes, so that the hospital can work smarter and save costs.”
For further information, please contact:
Mark Groves
Philips Group Press Office
Tel: +31 631 639 916
Email: mark.groves@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 17.3 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachment


Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Philips N.V.mehr Nachrichten
20.02.25 |
ANALYSE-FLASH: JPMorgan senkt Ziel für Philips auf 22,60 Euro - 'Neutral' (dpa-AFX) | |
20.02.25 |
ANALYSE-FLASH: UBS hebt Philips auf 'Buy' - Ziel erhöht auf 29 Euro (dpa-AFX) | |
19.02.25 |
Philips-Aktie heftig unter Druck: Umsatzschwäche bleibt bestehen (dpa-AFX) | |
19.02.25 |
ANALYSE-FLASH: Bernstein belässt Philips auf 'Outperform' - Ziel 32 Euro (dpa-AFX) | |
19.02.25 |
ANALYSE-FLASH: Barclays belässt Philips auf 'Overweight' - Lobt Aufträge bei D&T (dpa-AFX) | |
19.02.25 |
ANALYSE-FLASH: UBS belässt Philips auf 'Neutral' - Ziel 26,50 Euro (dpa-AFX) | |
19.02.25 |
Umsatzschwäche von Medizintechnikkonzern Philips hält an - Aktie rutscht ab (dpa-AFX) | |
29.10.24 |
ANALYSE-FLASH: Jefferies hebt Philips auf 'Hold' - Ziel hoch auf 25 Euro (dpa-AFX) |
Analysen zu Philips N.V.mehr Analysen
21.02.25 | Philips Buy | UBS AG | |
21.02.25 | Philips Buy | Goldman Sachs Group Inc. | |
20.02.25 | Philips Halten | DZ BANK | |
20.02.25 | Philips Hold | Deutsche Bank AG | |
20.02.25 | Philips Neutral | JP Morgan Chase & Co. |
Aktien in diesem Artikel
Philips N.V. | 24,79 | 2,44% |
|